XML 148 R97.htm IDEA: XBRL DOCUMENT
v3.22.4

Equity (Share-based Payments to Employees, Non-marketable Options) (Details) - Non-marketable options [Member] shares in Thousands | 12 Months Ended
--- | ---
Dec. 31, 2022 shares
Officers and senior employees [Member] | August 6, 2014 [Member] |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |
Number of instruments (thousands) | 3,993 |
Issuance's details | A |
Instrument terms | Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company. In case that on the exercise date the closing price of an ordinary share is higher than twice the exercise price (the “Share Value Cap”), the number of the exercised shares will be reduced so that the product of the exercised shares actually issued to an offeree multiplied by the share closing price will equal to the product of the number of exercised options multiplied by the Share Value Cap. |
Vesting conditions | 3 equal tranches: (1) one third on December 1, 2016 (2) one third on December 1, 2017 (3) one third on December 1, 2018 |
Expiration date | Two years from the vesting date. |
Officers and senior employees [Member] | June 30, 2016 [Member] |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |
Number of instruments (thousands) | 3,035 |
Issuance's details | A |
Instrument terms | Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company. |
Vesting conditions | 3 equal tranches: (1) one third at the end of 12 months after the grant date (2) one third at the end of 24 months after the grant date (3) one third at the end of 36 months after the grant date |
Expiration date | June 30, 2023 |
Officers and senior employees [Member] | June 20, 2017 [Member] |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |
Number of instruments (thousands) | 6,868 |
Issuance's details | A |
Instrument terms | Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company. |
Vesting conditions | 3 equal tranches: (1) one third at the end of 12 months after the grant date (2) one third at the end of 24 months after the grant date (3) one third at the end of 36 months after the grant date |
Expiration date | June 20, 2024 |
Officers and senior employees [Member] | March 6, 2018 [Member] |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |
Number of instruments (thousands) | 5,554 |
Issuance's details | A |
Instrument terms | Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company. |
Vesting conditions | 3 equal tranches: (1) one third at the end of 12 months after the grant date (2) one third at the end of 24 months after the grant date (3) one third at the end of 36 months after the grant date |
Expiration date | March 6, 2025 |
Former chairman of BOD [Member] | September 5, 2016 [Member] |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |
Number of instruments (thousands) | 186 |
Issuance's details | A |
Instrument terms | Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company. |
Vesting conditions | 3 equal tranches: (1) one third at the end of 12 months after the grant date (2) one third at the end of 24 months after the grant date (3) one third at the end of 36 months after the grant date |
Expiration date | June 30, 2023 |
Former chairman of BOD [Member] | August 2, 2017 [Member] |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |
Number of instruments (thousands) | 165 |
Issuance's details | A |
Instrument terms | Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company. |
Vesting conditions | 3 equal tranches: (1) one third at the end of 12 months after the grant date (2) one third at the end of 24 months after the grant date (3) one third at the end of 36 months after the grant date |
Expiration date | June 20, 2024 |
Former chairman of BOD [Member] | August 20, 2018 [Member] |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |
Number of instruments (thousands) | 403 |
Issuance's details | An issuance of non-marketable and non-transferrable options, for no consideration, under the amended 2014 Equity Compensation Plan. |
Instrument terms | Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company. |
Vesting conditions | 3 equal tranches: (1) one third at the end of 12 months after the grant date (2) one third at the end of 24 months after the grant date (3) one third at the end of 36 months after the grant date |
Expiration date | August 20, 2025 |
Former CEO [Member] | February 14, 2017 [Member] |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |
Number of instruments (thousands) | 114 |
Issuance's details | A |
Instrument terms | Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company. |
Vesting conditions | 3 equal tranches: (1) one third at the end of 12 months after the grant date (2) one third at the end of 24 months after the grant date (3) one third at the end of 36 months after the grant date |
Expiration date | February 14, 2024 |
CEO [Member] | May 14, 2018 [Member] |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |
Number of instruments (thousands) | 385 |
Issuance's details | An issuance of non-marketable and non-transferrable options, for no consideration, under the amended 2014 Equity Compensation Plan. | [1]
Instrument terms | Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company. |
Vesting conditions | 3 equal tranches: (1) one third at the end of 12 months after the grant date (2) one third at the end of 24 months after the grant date (3) one third at the end of 36 months after the grant date |
Expiration date | May 14, 2025 |
CEO [Member] | June 27, 2019 [Member] |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |
Number of instruments (thousands) | 3,512 |
Issuance's details | An issuance of non-marketable and non-transferrable options, for no consideration, under the amended 2014 Equity Compensation Plan. |
Instrument terms | Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company. |
Vesting conditions | 2 equal tranches:(1) half at the end of 24 months after the grant date.(2) half at the end of 36 months after the grant date. |
Expiration date | 5 years after the grant date |
CEO [Member] | March 30, 2022 [Member] |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |
Number of instruments (thousands) | 1,941 |
Issuance's details | An issuance of non-marketable and non-transferrable options, for no consideration, under the amended 2014 Equity Compensation Plan. |
Instrument terms | Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company. |
Vesting conditions | 3 equal tranches: (1) one third at the end of 12 months after the grant date (2) one third at the end of 24 months after the grant date (3) one third at the end of 36 months after the grant date |
Expiration date | 5 years after the grant date |
Officers and senior manager [Member] | April 15, 2019 [Member] |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |
Number of instruments (thousands) | 13,242 |
Issuance's details | An issuance of non-marketable and non-transferrable options, for no consideration, under the amended 2014 Equity Compensation Plan. |
Instrument terms | Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company. |
Vesting conditions | 2 equal tranches:(1) half at the end of 24 months after the grant date.(2) half at the end of 36 months after the grant date. |
Expiration date | 5 years after the grant date |
Chairman BOD [Member] | May 29, 2019 [Member] |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |
Number of instruments (thousands) | 2,169 | [1]
Issuance's details | An issuance of non-marketable and non-transferrable options, for no consideration, under the amended 2014 Equity Compensation Plan. | [1]
Instrument terms | Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company. | [1]
Vesting conditions | 2 equal tranches:(1) half at the end of 24 months after the grant date.(2) half at the end of 36 months after the grant date. | [1]
Expiration date | 5 years after the grant date | [1]
Chairman BOD [Member] | March 30, 2022 [Member] |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |
Number of instruments (thousands) | 1,055 |
Issuance's details | An issuance of non-marketable and non-transferrable options, for no consideration, under the amended 2014 Equity Compensation Plan. |
Instrument terms | Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company. |
Vesting conditions | 3 equal tranches: (1) one third at the end of 12 months after the grant date (2) one third at the end of 24 months after the grant date (3) one third at the end of 36 months after the grant date |
Expiration date | 5 years after the grant date |
Senior Employees [Member] | June 30, 2021 [Member] |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |
Number of instruments (thousands) | 647 |
Issuance's details | An issuance of non-marketable and non-transferrable options, for no consideration, under the amended 2014 Equity Compensation Plan. |
Instrument terms | Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company. |
Vesting conditions | 2 equal tranches:(1) half at the end of 24 months after the grant date.(2) half at the end of 36 months after the grant date. |
Expiration date | 5 years after the grant date |
Senior Employees [Member] | February 8, 2022 [Member] |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |
Number of instruments (thousands) | 9,294 |
Issuance's details | An issuance of non-marketable and non-transferrable options, for no consideration, under the amended 2014 Equity Compensation Plan. |
Instrument terms | Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company. |
Vesting conditions | 3 equal tranches: (1) one third at the end of 12 months after the grant date (2) one third at the end of 24 months after the grant date (3) one third at the end of 36 months after the grant date |
Expiration date | 5 years after the grant date |
[1] | The options were issued upon Mr. Doppelt's entry into office on July 1, 2019.

X
- References No definition available. + Details
Name: | icl_NumberOfInstruments
Namespace Prefix: | icl_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The description of the maximum term of options granted for a type of share-based payment arrangement that existed at any time during the period. An entity with substantially similar types of share-based payment arrangements may aggregate this information. [Refer: Share-based payment arrangements [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2022-03-24 -Paragraph 45 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_a&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The description of the method of settlement (for example, whether in cash or equity) for a type of share-based payment arrangement that existed at any time during the period. An entity with substantially similar types of share-based payment arrangements may aggregate this information. [Refer: Share-based payment arrangements [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2022-03-24 -Paragraph 45 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_a&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The description of the vesting requirements for a type of share-based payment arrangement that existed at any time during the period. An entity with substantially similar types of share-based payment arrangements may aggregate this information. [Refer: Share-based payment arrangements [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2022-03-24 -Paragraph 45 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_a&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The description of a share-based payment arrangement that existed at any time during the reporting period. [Refer: Share-based payment arrangements [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2022-03-24 -Paragraph 45 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_a&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_ExplanationOfShareOptionsInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_ClassesOfShareCapitalAxis=icl_NonmarketableOptionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_EmployeeFunctionAxis=icl_OfficersAndSeniorEmployeesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_GrantDateAxis=icl_August62014Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_GrantDateAxis=icl_June302016Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_GrantDateAxis=icl_June202017Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_GrantDateAxis=icl_March62018Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_EmployeeFunctionAxis=icl_FormerChairmanBODMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_GrantDateAxis=icl_September52016Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_GrantDateAxis=icl_August22017Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_GrantDateAxis=icl_August202018Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_EmployeeFunctionAxis=icl_FormerCEOMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_GrantDateAxis=icl_February142017Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_EmployeeFunctionAxis=icl_CEOMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_GrantDateAxis=icl_May142018Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_GrantDateAxis=icl_June272019Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_GrantDateAxis=icl_March302022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_EmployeeFunctionAxis=icl_OfficersAndSeniorManagerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_GrantDateAxis=icl_April152019Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_EmployeeFunctionAxis=icl_ChairmanBODMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_GrantDateAxis=icl_May292019Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_EmployeeFunctionAxis=icl_SeniorEmployeesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_GrantDateAxis=icl_June302021Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | icl_GrantDateAxis=icl_February82022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |